Investor Type | Firm |
Type of Fund | VC |
Industries | Software (Web Marketplace Saas..) • PropTech • Education • Businesses Solutions • Retail (& E-Commerce) • Entertainment (& Sports) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Blockchain (& Cryptos) • Gaming (& eSports) • Medical Devices (& Hospital Services) • Real Estate (& Construction) • Healthcare (& Wellness) • Online Social • Consumer |
Stages | Expansion, MBO/LBO, Turnaround, Restructuring, PIPE, Privatization, Secondary Purchase, Seed, Series A, Convertible Note, Series C, Series B |
Investing | United States • United Kingdom • Canada • Germany • India • Japan • France • Italy • Spain • South Africa • China • Switzerland • Netherlands • Singapore • Hong Kong • Belgium • Austria • Europe • Norway • Middle East • Asia • Vietnam • Thailand • Malaysia |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Dreamers VC is an investment fund dedicated to seeking out transformative and innovative businesses primarily in the sectors of Software, including Web, Marketplace, SaaS; PropTech; Education; Business Solutions; Retail & E-Commerce; Entertainment & Sports; CleanTech; Artificial Intelligence & Big Data; HealthTech & Fitness; Blockchain & Cryptocurrencies; Gaming & eSports; Medical Devices & Hospital Services; Real Estate & Construction; Healthcare & Wellness; and Online Social, among other industries. They aim to contribute equity investments with a focus on companies positioned for expansion or undergoing management buyouts/leveraged buyouts (MBO/LBO), turnarounds, restructuring, private investment in public equity (PIPE), privatization, secondary purchases, or at various funding stages including Seed, Series A, Convertible Note, Series B, and Series C rounds. Dreamers VC has a broad investment range from a minimum of $100,000 to a maximum cap of $5,000,000, and they have a 'sweet spot' for investments at around $1,500,000. They look for ventures with certain criteria such as those in clinical phase 2 of therapeutic drug development; medical devices and diagnostics that either present a paradigm shift or boast a significant track record of success; companies addressing important unmet medical needs; those with a clear and efficient regulatory path in capital; experienced leadership with a proven track record of success; a solid and consolidated IP position; evidence of human efficacy or data in preferred patients; large addressable markets; diversified channeling with multiple 'shots on goal'; and indications and disease areas of interest in partnerships with large pharmaceutical companies. Their headquarters are located at Sabino Arana 12, Leioa, 48940 Spain.
We invest in : - Clinical phase 2 of therapeutic drug development. - Medical device and diagnostics, but only if the technology is a paradigm shift or if the equipment has a significant track record of success. - Important unmet medical needs - A clear and efficient regulatory path in capital - Experienced leadership with a track record of success - Solid and consolidated IP position - Evidence of human efficacy or data in preferred patients - Large addressable markets - Diversified channeling with multiple "shots on goal " - Indications and disease areas of interest in partnerships with large pharmaceutical companies